A B S T R A C T The recently described acquired immune deficiency syndrome (AIDS) is characterized by the occurrence of severe opportunistic infections and an aggressive form of Kaposi's sarcoma. A variety of profound defects in cell-mediated immunity have been reported in association with the AIDS, including deficiencies in natural killer (NK) cell activity and cytomegalovirus (CMV)-specific cytotoxicity. In the present study, the in vitro effects of interleukin-2 (IL-2) and interferon beta (IFN Beta) on these abnormalities were examined to assess the potential use of these lymphokines in the immunotherapeutic treatment of this syndrome. The peripheral blood lymphocytes (PBL) from six male homosexuals with AIDS and an active CMV infection exhibited markedly depressed NK cell and CMV-specific cytotoxic lymphocyte responses compared with uninfected, heterosexual control subjects. Incubation of PBL with IFN Beta enhanced the NK cell activity and the CMV-specific cytotoxicity of only one of six and neither of two AIDS
INTRODUCTION
Since 1978, more than 1,800 individuals have developed the acquired immune deficiency syndrome (AIDS),' which is characterized by severe defects in cellular immunity, opportunistic infections with agents such as cytomegalovirus (CMV), Herpes-simplex virus, and Pneumocystis carinii, and an unusually aggressive form of Kaposi's sarcoma (1) (2) (3) . None of the patients with AIDS has regained immune function. The current mortality rate for all diagnosed cases is 40%; however, with time, mortality may approach 100% (1) . In a preliminary report, we described abnormalities in natural killer (NK) and cytomegalovirus-specific cytotoxic lymphocyte activities in AIDS patients (4) . In other immunosuppressed individuals, and more specifically, in transplant patients, these cytotoxic lymphocyte activities are important determinants of recovery from CMV infection (5, 6) . Since the lymphokines interferon (IFN) and interleukin-2 (IL-2) may enhance NK cell and cytotoxic T cell (CTL) activities (7-9), we performed studies to determine if they could augment the depressed cytotoxic activities of lymphocytes from patients with AIDS. We report here that patients with AIDS and CMV infection had a marked depression in their NK cell and CMV-specific cytotoxic lymphocyte activities which could be restored to normal levels by in vitro incubation of their lymphocytes with highly purified IL-2. IFN Beta did not enhance the NK cell or the CMV-specific cytotoxic lymphocyte activities of the AIDS patients, although it did produce a significant increase in the NK cell activity of normal control subjects.
METHODS
Patient population. The patient group consisted of six male homosexuals with a clinical diagnosis of AIDS. The diagnosis was based upon the Centers for Disease Control's definition of AIDS as the occurrence in a previously healthy individual of a disease that is at least moderately predictive of a defect in cell-mediated immunity (1) . These men were 25 to 48 yr old (mean 39 yr); four were Caucasian and two were Black. All 
RESULTS
The results of NK cell assays are shown in Fig. 1 . The mean (±1 SEM) NK cell activity of lymphocytes from the patients with AIDS was 29.8±6.5%. This was significantly below (P = 0.007) the mean of 60.2±6. 4% for the six normal volunteers tested in this study. In vitro incubation of lymphocytes with IFN Beta resulted in significant enhancement of NK cell activity in only one of six AIDS patients and all six normal volunteers (Fig. 1) . However, exposure of these same lymphocytes to IL-2 for 1 h significantly enhanced NK cell activity in all six AIDS patients and five of five normal volunteers tested (Fig. 2) The results of the CMV-specific cytotoxicity assays are shown in Fig. 3 . Lymphocytes from the six normal, uninfected volunteers had significant CMV-specific cytotoxicity against both HLA-matched and mismatched target cells, as has been described previously (13) . After exposure of the normal lymphocytes to IL-2 for 72 h, only one individual had significant enhancement of their activity. Four AIDS patients had no detectable CMV-specific cytotoxicity. The other two AIDS patients had low levels of CMV-specific cytotoxicity that did not exceed 3.5%. Two AIDS patients without detectable CMV-specific cytotoxicity had no increase in this activity after their lymphocytes were cultured in IFN Beta for 72 h (data not shown). In contrast, after AIDS lymphocytes were cultured for 72 h in IL-2, the mean CMV-specific cytotoxic activity against both HLA-matched and mismatched targets increased significantly from pretreatment values (P < 0.001). In five of six patients tested, lysis of HLAmatched and mismatched targets was comparable. Thus, the IL-2 enhanced CMV-specific cytotoxic activity was not HLA-restricted (significant lysis of HLAmatched target cells with no lysis of mismatched targets). 
DISCUSSION
We studied homosexual men with Kaposi's sarcoma and/or opportunistic infections who had active CMV infections. In these patients, NK cell and CMV-specific cytotoxic lymphocyte activities were depressed. The cultivation of lymphocytes with IFN Beta enhanced NK cell activity and CMV-specific cytotoxicity in only one of six and neither of two patients, respectively, whereas both CMV-specific and NK cell cytotoxicity were significantly enhanced by IL-2. Furthermore, the level of cytotoxic lymphocyte activity measurable after treatment of their lymphocytes with IL-2 was comparable to levels measurable in normal subjects. The importance of cytotoxic lymphocytes in recovery from CMV infection has been demonstrated in studies of bone marrow and renal transplant recipients (5, 6, 14) . In uninfected healthy individuals, regardless of their CMV antibody status, circulating lymphocytes are found that kill CMV-infected target cells (13) . These lymphocytes have properties of NK cells and are not HLA-restricted. During acute CMV infection, CMV-specific cytotoxicity increases (5) . The responding cells may be HLA-restricted cytotoxic T cells (CTL) or nonrestricted, non-T lymphocytes (with properties of NK cells) or both (5) . The failure of transplant patients to develop CMV-specific cytotoxic responses is uniformly associated with either severe and complicated or fatal infections. In these same transplant patients with absent CMV-specific cytotoxic responses, NK cell activity, measured using tumor cells as target cells, is also deficient.
The results of our study indicated that the AIDS patients had deficiencies in both CMV-specific and NK cell cytotoxic lymphocyte activities. The patients' were deficient in two respects. Their CMV-specific cytotoxicity was substantially lower than that measured in normal volunteers. In addition, despite having active CMV infections, they did not have HLA-restricted T cell-mediated cytotoxic responses. These deficiencies are probably related to their enhanced susceptibility to CMV infection.
The cytotoxic activities of lymphocytes from all the patients in this study were enhanced by exposure to IL-2. The effect of IL-2 can be understood in the context of the known effects of this lymphokine on various types of cytotoxic lymphocytes. IL-2 enhances NK cell activity (9) . Similarly, the in vivo generation of CTL responses to alloantigens can be augmented by IL-2 (9) . However, the effect of IL-2 on the in vitro production of HLA-restricted, virus-specific CTL has not been well studied. This latter response can be obtained 
